S. 252 · 115th Congress
Medicare Drug Savings Act of 2017
- Stage
- In committee
- Sponsor
- Bill Nelson
- Introduced
- 2017-02-01
- Latest action
- 2017-02-01 · Introduced in Senate
Summary
Medicare Drug Savings Act of 2017
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for prescription drugs dispensed to eligible low-income individuals under the Medicare prescription drug benefit or a Medicare Advantage (MA) prescription drug plan (PDP).
Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report, both to drug manufacturers and to the CMS, specified information related to the determination and payment of such rebates.